1. Home
  2. ACXP vs BANL Comparison

ACXP vs BANL Comparison

Compare ACXP & BANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • BANL
  • Stock Information
  • Founded
  • ACXP 2017
  • BANL 2015
  • Country
  • ACXP United States
  • BANL Malaysia
  • Employees
  • ACXP N/A
  • BANL N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • BANL Oil Refining/Marketing
  • Sector
  • ACXP Health Care
  • BANL Energy
  • Exchange
  • ACXP Nasdaq
  • BANL Nasdaq
  • Market Cap
  • ACXP 8.4M
  • BANL 25.3M
  • IPO Year
  • ACXP 2021
  • BANL 2023
  • Fundamental
  • Price
  • ACXP $0.43
  • BANL $0.80
  • Analyst Decision
  • ACXP Strong Buy
  • BANL
  • Analyst Count
  • ACXP 2
  • BANL 0
  • Target Price
  • ACXP $10.00
  • BANL N/A
  • AVG Volume (30 Days)
  • ACXP 18.7M
  • BANL 463.9K
  • Earning Date
  • ACXP 08-08-2025
  • BANL 04-16-2025
  • Dividend Yield
  • ACXP N/A
  • BANL N/A
  • EPS Growth
  • ACXP N/A
  • BANL N/A
  • EPS
  • ACXP N/A
  • BANL N/A
  • Revenue
  • ACXP N/A
  • BANL $592,517,545.00
  • Revenue This Year
  • ACXP N/A
  • BANL N/A
  • Revenue Next Year
  • ACXP N/A
  • BANL N/A
  • P/E Ratio
  • ACXP N/A
  • BANL N/A
  • Revenue Growth
  • ACXP N/A
  • BANL 35.93
  • 52 Week Low
  • ACXP $0.30
  • BANL $0.55
  • 52 Week High
  • ACXP $3.33
  • BANL $1.35
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 46.13
  • BANL 47.03
  • Support Level
  • ACXP $0.45
  • BANL $0.71
  • Resistance Level
  • ACXP $0.59
  • BANL $1.03
  • Average True Range (ATR)
  • ACXP 0.07
  • BANL 0.07
  • MACD
  • ACXP -0.01
  • BANL -0.01
  • Stochastic Oscillator
  • ACXP 10.73
  • BANL 27.44

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

Share on Social Networks: